
Find Reports
Select Report Type
Reimbursement Review
Displaying 1076 - 1100 of 1422
Please scroll or swipe to the right to view the full content.
Title | Brand Name | Generic Name | Files | Therapeutic Area | Recommendation Type | Status | Submission Date | Recommendation Date Sort ascending | Project Number |
---|---|---|---|---|---|---|---|---|---|
lurasidone | Latuda | lurasidone | Bipolar I disorder | Canada’s Drug Agency is unable to make a reimbursement recommendation as the manufacturer has not filed a submission. | Not filed | NS0010-000 | |||
etonogestrel | TBC | etonogestrel | Prevention of pregnancy | Withdrawn | SR0629-000 | ||||
CADTH Pharmaceutical Reviews U... | |||||||||
CADTH Pharmaceutical Reviews U... | |||||||||
CADTH Pharmaceutical Reviews U... | |||||||||
Orilissa (elagolix) | Orilissa | elagolix | Moderate to severe pain associated with endometriosis | Canada’s Drug Agency is unable to make a reimbursement recommendation as the manufacturer has not filed a submission. | Not filed | NS0011-000 | |||
CADTH Pharmaceutical Reviews U... | |||||||||
CADTH Pharmaceutical Reviews U... | |||||||||
pembrolizumab | Keytruda | pembrolizumab | Gastrointestinal Cancer | Canada’s Drug Agency is unable to make a reimbursement recommendation as the manufacturer has not filed a submission. | Not filed | NS0012-000 | |||
CADTH Pharmaceutical Reviews U... | |||||||||
CADTH Pharmaceutical Reviews U... | |||||||||
CADTH Pharmaceutical Reviews U... | |||||||||
natalizumab | Tysabri | natalizumab | Multiple Sclerosis, relapsing-remitting | Withdrawn | SR0687-000 | ||||
CADTH Pharmaceutical Reviews U... | |||||||||
CADTH Pharmaceutical Reviews U... | |||||||||
CADTH Pharmaceutical Reviews U... | |||||||||
aducanumab | Aduhelm | aducanumab | Alzheimer’s disease | Withdrawn | SR0705-000 | ||||
pembrolizumab and lenvatinib | Keytruda and Lenvima | pembrolizumab and lenvatinib | Advanced endometrial cancer | Withdrawn | PC0271-000 | ||||
CADTH Pharmaceutical Reviews U... | |||||||||
CADTH Pharmaceutical Reviews U... | |||||||||
CADTH Pharmaceutical Reviews U... | |||||||||
CADTH Pharmaceutical Reviews U... | |||||||||
abaloparatide | TBC | abaloparatide | Osteoporosis, postmenopausal women | Withdrawn | SR0744-000 | ||||
CADTH Pharmaceutical Reviews U... | |||||||||
CADTH Pharmaceutical Reviews U... |
Health Technology Review
Displaying 576 - 600 of 600
Horizon Scan
Displaying 101 - 110 of 110
Projects in Progress
Displaying 26 - 27 of 27
View All Reports
Displaying 1076 - 1100 of 2132
Please scroll or swipe to the right to view the full content.